CLLS
Companies
NASDAQ
Cellectis S.A. - ADR
Health Care
$1.40
-$0.40 (-22.22%)
Price Chart
Overview
About CLLS
Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company's gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. It reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology.
Market Cap
$257.2M
Volume
60.8K
Avg. Volume
104.1K
P/E Ratio
-2.0789475
Dividend Yield
0.00%
Employees
249.0
Company Information
Risk & Correlation Analysis
Market Correlation
2.23
High Correlation
Volatility
High (0.85)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CLLS shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$257.2M
Volume60.8K
P/E Ratio-2.08
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 26, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025